ITHS Tools
Login
Need Help? Have a Question?
Connect with Us
 

ITHS Blog

A key component of the Institute of Translational Health Sciences’ Community-Engaged Research and Regional Collaborations program is its Regional Advisory Workgroup. The Workgroup supports ITHS’ regional collaboration efforts, helping ITHS to focus its attention on issues of importance to translational science in the five-state WWAMI...

The Association for Clinical and Translational Science has accepted four abstracts from the Institute of Translational Health Sciences (ITHS) for poster presentation at the Translational Science 2014 Meeting, which will take place April 9 to 11, 2014, in Washington, DC. The accepted abstracts discuss the...

The Institute of Translational Health Sciences (ITHS), in partnership with the Northwest Association for Biomedical Research and Fred Hutch, hosted a panel discussion and networking reception for National Institutes of Health K-Award recipients on February 27, 2014. The event, which was the first of its...

Evaluation & the Health Professions recently published a journal article written by a group of Institute of Translational Health Sciences (ITHS) faculty and staff describing ITHS’ hybrid approach to program evaluation. The authors, led by Dr. Craig S. Scott (pictured), detailed their rationale for focusing on...

The Institute of Translational Health Sciences launched its new newsletter, the ITHS Research Connector, earlier today. The goal of this newsletter is to highlight some of the many ITHS resources and tools available to researchers. The newsletter will also share researcher success stories. The first issue...

Bioethics Role with ITHS Facilitates Response to SUPPORT Study Dr. Benjamin Wilfond is an attending pediatric pulmonologist and Director of the Treuman Katz Center for Pediatric Bioethics at Seattle Children’s Hospital. Given his passion for pediatric pulmonology and bioethics, it is not surprising that he developed...

The PENUT (Preterm Epo Neuroprotection) trial is a new study being led by University of Washington researchers who are assessing whether erythropoietin (Epo) can provide neurological protection for infants who are born extremely prematurely. This study is seeking a treatment for the approximately 50,000 infants...